EP1013
EP1013 (F1013) is a broad-spectrum caspase selective inhibitor, used in the research of type 1 diabetes[1].
Product Specifications
CAS Number
223568-55-6
Product Name Alternative
F1013
UNSPSC
12352005
Target
Caspase
Type
Reference compound
Related Pathways
Apoptosis
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/EP1013.html
Concentration
10mM
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(O)C[C@H](NC([C@H](C(C)C)NC(OCC1=CC=CC=C1)=O)=O)C(CF)=O
Molecular Formula
C18H23FN2O6
Molecular Weight
382.38
References & Citations
[1]Emamaullee JA, et al. The caspase selective inhibitor EP1013 augments human islet graft function and longevity in marginal mass islet transplantation in mice. Diabetes. 2008 Jun;57 (6) :1556-66.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
Caspase
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
K0245502 1.0 µg DNA
C6orf89 sgRNA CRISPR Lentivector (Human) (Target 1)
Sign In for Pricing
View Details